Price (delayed)
$17.6
Market cap
$868.13M
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$0.41
Enterprise value
$762.71M
STAAR, which has been dedicated solely to ophthalmic surgery for over 30 years, designs, develops, manufactures and markets implantable lenses for the eye with companion delivery systems. These lenses are
There are no recent dividends present for STAA.
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise
specified. Data from and Sharadar.